Health Catalyst (HCAT) Projected to Announce Earnings on Thursday

Health Catalyst (NASDAQ:HCAT) is anticipated to issue its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect Health Catalyst to post earnings of $0.02 per share and revenue of $69.0030 million for the quarter. Parties can check the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, August 6, 2026 at 5:00 PM ET.

Health Catalyst (NASDAQ:HCAT) last announced its quarterly earnings data on Monday, May 11th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.01. The company had revenue of $70.76 million during the quarter, compared to analysts’ expectations of $69.24 million. Health Catalyst had a negative net margin of 87.69% and a negative return on equity of 3.52%. On average, analysts expect Health Catalyst to post $-0 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Health Catalyst Trading Up 5.7%

HCAT stock opened at $2.21 on Tuesday. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 1.10. The company has a market cap of $163.30 million, a price-to-earnings ratio of -0.59 and a beta of 1.55. The business has a fifty day simple moving average of $1.91 and a 200-day simple moving average of $1.71. Health Catalyst has a 52 week low of $0.96 and a 52 week high of $3.88.

Analyst Ratings Changes

A number of equities research analysts have issued reports on HCAT shares. Wells Fargo & Company boosted their price target on Health Catalyst from $1.00 to $1.75 and gave the company an “equal weight” rating in a research report on Friday, June 26th. Citigroup restated a “neutral” rating on shares of Health Catalyst in a report on Thursday, July 23rd. Stephens reduced their price objective on Health Catalyst from $2.00 to $1.75 and set an “equal weight” rating on the stock in a research note on Tuesday, May 12th. Canaccord Genuity Group boosted their target price on Health Catalyst from $2.00 to $3.00 and gave the stock a “buy” rating in a report on Tuesday, July 21st. Finally, Cantor Fitzgerald reissued a “neutral” rating on shares of Health Catalyst in a research report on Monday, May 11th. Four research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $2.93.

Institutional Investors Weigh In On Health Catalyst

A number of large investors have recently modified their holdings of HCAT. Jain Global LLC acquired a new position in shares of Health Catalyst during the fourth quarter worth $124,000. Jump Financial LLC grew its holdings in Health Catalyst by 124.5% during the 4th quarter. Jump Financial LLC now owns 59,000 shares of the company’s stock valued at $141,000 after purchasing an additional 32,717 shares in the last quarter. State of Wyoming increased its stake in Health Catalyst by 97.3% during the 4th quarter. State of Wyoming now owns 67,573 shares of the company’s stock worth $161,000 after buying an additional 33,320 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Health Catalyst during the 3rd quarter worth $90,000. Finally, Jane Street Group LLC acquired a new position in Health Catalyst in the 2nd quarter worth $173,000. Institutional investors and hedge funds own 85.00% of the company’s stock.

About Health Catalyst

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.